One family member, ErbB2 is expressed within B-lymphoid blast cells from patients with ALL and CML [3], [4]; however, these studies did not examine ErbB2 expression or activity across ALL subtypes including Ph+ALL. This evidence concerns the gene ERBB2 and chronic myelogenous leukemia, BCR-ABL1 positive.